Studies of Parkinson's disease have long overlooked Pacific populations—meta-analysis ...
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
Generic Drug Maker Amneal Pharmaceuticals Is Positioned To Growth Well Ahead Of Peers ...
J.P. Morgan has upgraded Amneal Pharmaceuticals, Inc (NASDAQ:AMRX), noting the company’s generics business is increasingly ...
The Pharma Letter2 天
EMA accepts MAA for ND0612 in Parkinson’s disease
Mitsubishi Tanabe Pharma (MTPC) today announced that the European Medicines Agency (EMA) has accepted for review the ...
IRLAB Receives Positive Feedback from EMA Confirming Alignment with FDA on Phase III ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 20 February, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB a company ...
IRLAB Therapeutics: IRLAB Receives Positive Feedback from EMA Confirming Alignment with FDA ...
GOTHENBURG, SWEDEN / ACCESS Newswire / February 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 20 February, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB a company d ...
manilatimes7 天
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson's ...
Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
Ask Dr James: What do vivid hallucinations really mean?
In his regular column, Dr James Le Fanu answers your questions. This week, a reader is concerned by a neighbour who is ...
Parkinson's Disease Treatment Market To Worth USD 3.71 Billion By 2032 SNS Insider
Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...
Addex Therapeutics Ltd (NASDAQ:ADXN) Sees Large Drop in Short Interest
Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the target of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,500 ...
IRLAB Therapeutics: IRLAB Publishes Full-Year Report for 2024
GOTHENBURG, SE / ACCESS Newswire / February 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 12, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company d ...
Pharm Exec18 天
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in ...
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.
Parkinson’s Disease Market is anticipated to Grow at a CAGR of 5.8% During the Study ...
According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately 1,210 thousand in the US in 2023 which is expected to increase during the ...